生长抑素辅助治疗老年急性糜烂出血性胃炎大出血的效果分析
2014-09-12王细金
王细金
[摘要] 目的 探讨生长抑素辅助治疗老年急性糜烂出血性胃炎大出血的临床效果。 方法 收集2012年8月~2013年8月本院消化内科收治的急性糜烂出血性胃炎老年患者32例,按照随机原则将其分为观察组和对照组各16例,对照组给予常规治疗,观察组在常规治疗基础上给予生长抑素辅助治疗。观察两组患者的临床疗效、总住院天数、7 d内出血复发率及不良反应。 结果 对照组总有效率为81.25%,观察组总有效率为93.75%,观察组总有效率高于对照组,差异有统计学意义(P<0.05)。观察组总住院天数短于对照组,差异有统计学意义(P<0.05)。对照组7 d内出血复发率为12.50%,观察组7 d内出血复发率为0,两组患者7 d内出血复发率差异有统计学意义(P<0.05)。对照者不良反应发生率为25.00%,观察组不良反应发生率为12.50%,两组患者不良反应发生率差异有统计学意义(P<0.05)。 结论 生长抑素辅助治疗老年急性糜烂出血性胃炎止血迅速、疗效显著且不良反应发生率低,可广泛应用于老年急性糜烂出血性胃炎的治疗。
[关键词] 生长抑素;老年急性糜烂出血性胃炎;大出血
[中图分类号] R975[文献标识码] A[文章编号] 1674-4721(2014)06(c)-0068-03
Effect analysis of somatostatin as an adjuvant therapy on massive hemorrhage in elderly patients with acute erosive hemorrhagic gastritis
WANG Xi-jin
Department of Gastroenterology,Affiliated Hospital of Jiujiang University,Jiujiang 332000,China
[Abstract] Objective To discuss the clinical effect of somatostatin as an adjuvant therapy on massive hemorrhage in elderly patients with acute erosive hemorrhagic gastritis. Methods Thirty-two elderly patients with acute erosive hemorrhagic gastritis in our department of gastroenterology from August 2012 to August 2013 were selected as research objects.They were evenly divided into observation group and control group in random.In the control group,patients were provided with conventional therapy,while in the observation group,adjuvant therapy of somatostatin was added on the basis of the control group.The clinical efficacy,total hospital stay,7 days hemorrhage recurrence rate and adverse reactions of two groups were observed. Results The total effective rate of the control group was 81.25%,of the observation group was 93.75%,the total effective rate of observation group was higher than that of control group,the difference was significant (P<0.05).The total hospital stay of observation group was shorter than that of control group,the difference was significant (P<0.05).7 days hemorrhage recurrence rate of the control group was 12.50%,of the observation group was 0,7 days hemorrhage recurrence rate of the observation group was lower than that of control group,the difference was significant (P<0.05).The incidence of adverse reactions in control group was 25.00%,in observation group was 12.50%,the incidence of adverse reactions in observation group was lower than that of control group,the difference was significant (P<0.05). Conclusion Somatostatin as an adjuvant therapy can stanch bleeding quickly in elderly patients with acute erosive hemorrhagic gastritis and obtain a remarkable effect,and has a low incidence of adverse reaction,which can be widely applied to treat elderly patients with acute erosive hemorrhagic gastritis.
[Key words] Somatostatin;Acute erosive hemorrhagic gastritis in the elderly;Massive hemorrhage
急性糜烂出血性胃炎以胃黏膜多发性糜烂为主要特征,在临床上比较常见,虽可发生于各个年龄段,但老年人血管条件差,急性糜烂出血性胃炎发病率近年来一直高居不下,严重时可以引起上消化道出血甚至危及患者的生命。据统计上消化道大出血患者的死亡率可达到40%,在所有上消化道出血患者中,因急性糜烂出血性胃炎导致者约为20%,故积极探索针对急性糜烂出血性胃炎老年患者的治疗方法就显得尤为重要[1]。本研究分析生长抑素辅助治疗老年急性糜烂出血性胃炎大出血的临床疗效。
1 资料与方法
1.1 一般资料
收集2012年8月~2013年8月本院消化内科收治的急性糜烂出血性胃炎老年患者32例作为研究对象。纳入标准[2]:①患者年龄55~79岁;②临床确诊为急性糜烂出血性胃炎发作;③临床表现为收缩压较病前下降、频繁便血、大量呕血等;……
